Michael Okunewitch
Stock Analyst at Maxim Group
(0.25)
# 4,567
Out of 5,043 analysts
382
Total ratings
35.7%
Success rate
-4.5%
Average return
Main Sectors:
Stocks Rated by Michael Okunewitch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRTX BioRestorative Therapies | Downgraded: Hold | n/a | $1.91 | - | 24 | Oct 6, 2026 | |
| AIDX 20/20 Biolabs | Rated: Buy | n/a | $0.375 | - | 3 | Oct 2, 2026 | |
| HCWB HCW Biologics | Reiterated: Buy | $30 → $8 | $1.60 | +400.00% | 25 | Oct 2, 2026 | |
| LGVN Longeveron | Reiterated: Hold | n/a | $2.48 | - | 26 | Sep 18, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $8 | $0.9555 | +737.26% | 24 | Sep 16, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $55 | $36.90 | +49.05% | 17 | Sep 15, 2026 | |
| EVAX Evaxion | Reiterated: Buy | $10 | $3.07 | +225.73% | 4 | Aug 26, 2026 | |
| KPRX Kiora Pharmaceuticals | Reiterated: Buy | $12 | $2.54 | +372.44% | 33 | Aug 20, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $5 | $0.799 | +525.78% | 16 | Aug 20, 2026 | |
| VNRX VolitionRx | Reiterated: Buy | n/a | $0.2113 | - | 4 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $154.49 | +29.46% | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $12.54 | +139.23% | 28 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.91 | +266.49% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.994 | +201.81% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4 | $0.8398 | +376.30% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $12.00 | +66.67% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $151.17 | +9.15% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.38 | +262.32% | 13 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.13 | - | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $12 | $1.73 | +593.64% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.13 | +1,227.43% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.35 | - | 6 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.4994 | n/a | 28 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6.9 | $1.34 | n/a | 6 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.12 | n/a | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.32 | n/a | 11 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.4827 | n/a | 4 | May 9, 2023 |
BioRestorative Therapies
Oct 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.91
Upside: -
20/20 Biolabs
Oct 2, 2026
Rated: Buy
Price Target: n/a
Current: $0.375
Upside: -
HCW Biologics
Oct 2, 2026
Reiterated: Buy
Price Target: $30 → $8
Current: $1.60
Upside: +400.00%
Longeveron
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.48
Upside: -
Ocugen
Sep 16, 2026
Reiterated: Buy
Price Target: $8
Current: $0.9555
Upside: +737.26%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $55
Current: $36.90
Upside: +49.05%
Evaxion
Aug 26, 2026
Reiterated: Buy
Price Target: $10
Current: $3.07
Upside: +225.73%
Kiora Pharmaceuticals
Aug 20, 2026
Reiterated: Buy
Price Target: $12
Current: $2.54
Upside: +372.44%
Rani Therapeutics Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $5
Current: $0.799
Upside: +525.78%
VolitionRx
Aug 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.2113
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: $200
Current: $154.49
Upside: +29.46%
Aug 14, 2026
Reiterated: Buy
Price Target: $30
Current: $12.54
Upside: +139.23%
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.91
Upside: +266.49%
Aug 11, 2026
Reiterated: Buy
Price Target: $3
Current: $0.994
Upside: +201.81%
Aug 10, 2026
Rated: Buy
Price Target: $4
Current: $0.8398
Upside: +376.30%
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $12.00
Upside: +66.67%
Aug 6, 2026
Reiterated: Buy
Price Target: $165
Current: $151.17
Upside: +9.15%
Jul 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
May 4, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.13
Upside: -
Apr 9, 2026
Rated: Buy
Price Target: $10 → $12
Current: $1.73
Upside: +593.64%
Mar 25, 2026
Reiterated: Buy
Price Target: $15
Current: $1.13
Upside: +1,227.43%
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.35
Upside: -
Sep 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.4994
Upside: n/a
Sep 13, 2025
Reiterated: Hold
Price Target: $6.9
Current: $1.34
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $3.12
Upside: n/a
Sep 13, 2024
Reiterated: Buy
Price Target: $12
Current: $3.32
Upside: n/a
May 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $0.4827
Upside: n/a